✓ No loaded language, vague sourcing, or framing detected.
The FDA's Pharmacy Compounding Advisory Committee voted to allow compounding pharmacies to create peptides, despite opposition from agency scientists about their benefits. The decision followed a review of public comments and presentations on specific peptides.
Our neutral summary
The FDA's Pharmacy Compounding Advisory Committee voted to allow compounding pharmacies to create peptides, despite opposition from agency scientists about their benefits. The decision followed a review of public comments and presentations on specific peptides.
The reporting belongs to The Hill; we don't reproduce it.
No note attached
on this article.
FDA panel votes to add peptides to permitted compounding list despite opposition from agency scientists
FDA Panel Votes to Include Peptides in Compounding List